Volume 24, Number 1—January 2018
CME ACTIVITY - Synopsis
Zika Virus Testing and Outcomes during Pregnancy, Florida, USA, 2016
Table 5
Characteristic | Case-infant 1 | Case-infant 2 |
---|---|---|
Country of exposure | Haiti | Venezuela |
Gestational age at time of symptoms |
≈10 wk (2015 Nov) |
≈12 wk (2015 Dec) |
Laboratory results for Zika virus | ||
Mother | Serum IgM neg (April 2016) | Serum neg rRT-PCR, pos IgM (2016 Apr) |
Infant |
Serum/CSF neg rRT-PCR, pos IgM, pos PRNT >10 Zika virus (2016 May) |
Serum/CSF/CB neg rRT-PCR, pos IgM (2016 Jun) |
Antenatal ultrasound | HC <3%, BPD <3% (33.1 WGA) | HC 10%, BPD 34% (36.4 WGA) |
HC at birth |
30.5 cm (<1%) |
34 cm (25%–50%) |
Postnatal cranial imaging |
Serpiginous calcifications, R; polymicrogyriccortex, BL; simplified gyral pattern (BL, L >R) |
Linear calcifications, L; polymicrogyric cortex, R; atrophy cerebral peduncle, R; overall volume loss of entire brain, R >L |
Ocular evaluation | Unremarkable | Hypopigmented R superior retinal lesion |
Auditory evaluation | Unremarkable | Normal |
*BL, bilateral ; BPD, biparietal diameter; CSF, cerebrospinal fluid; HC, head circumference; L, left; neg, negative; pos, positive; PRNT, plague-reduction neutralization test; R, right; rRT-PCR, real-time reverse transcription PCR; WGA, weeks gestational age.
1These authors contributed equally to this article.
Page created: December 18, 2017
Page updated: December 18, 2017
Page reviewed: December 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.